Search - tctmd.com

Displaying 241 - 260 of 496

Sort: Relevancy | Date

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

Program Update: The ACCURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The ACURATE NEO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Alexandre Abizaid

June 22, 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presentation The Structural Heart Disease Summit 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Raj Makkar

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presentation The Structural Heart Disease Summit 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube

June 22, 2018

LAA Closure Plus: TAVR, MitraClip, PFO Closure, and More

Presentation The Structural Heart Disease Summit 2018

LAA Closure Plus: TAVR, MitraClip, PFO Closure, and More

Presenter: Ramon Quesada

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Who Shouldn't Undergo TAVR? Can We Identify the ‘Futile' Non-responders?

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Conductor (Illustrative Cases)

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of “Watchful Waiting” in Managing Asymptomatic Patients With Severe AS

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Status Update of the EARLY TAVR Trial – Asymptomatic Severe AS Patients

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Status Update of the TAVR UNLOAD Trial – Moderate AS Patients With Reduced Ejection Fraction

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.